Last edition
News about
Emcure Slashes Price of Semaglutide-Based Weight Loss Drug Poviztra in India
Emcure reduces the price of its semaglutide-based drug Poviztra, aiming to make effective weight management treatment more accessible to patients across India.
MHRA Approves Bayer's Sevabertinib for HER2-Mutated Advanced Lung Cancer
Sevabertinib, a targeted therapy for HER2-mutated lung cancer, has been approved by the UK regulator to expand treatment options for advanced-stage patients.
Merck Initiates Phase 2b/3 Trial of MK-8748 for Neovascular Age-Related Macular Degeneration
Merck initiates a Phase 2b/3 trial of MK-8748 (Tiespectus), a bispecific antibody targeting Tie2 and VEGF pathways for treatment of neovascular age-related macular degeneration.
NICE Recommends Weekly Semaglutide Injection to Prevent Heart Attacks and Strokes
NICE advises use of semaglutide injections for patients with prior cardiovascular conditions and excess weight to lower risk of future serious events.
Lupin Expands Specialty Care Business with VISUfarma Buyout
Lupin Limited has announced the completion of its acquisition of VISUfarma B.V. from GHO Capital Partners LLP, marking a significant step in strengthening its specialty care portfolio and expanding its footprint in Europe.
AiMeD Applauds Govt's Duty Waiver on Petrochemicals, Urges GST Cut to Ease Cost Pressures
The Association of Indian Medical Devices Industry (AiMeD) extends its sincere gratitude to the Government of India, particularly the Ministry of Finance and the Ministry of Commerce & Industry, for the prompt announcement of full customs duty temporary exemption on critical petrochemical products until June 30, 2026.
Vascarta's Curcumin Gel Shows Promising Results in Reducing Osteoarthritis Knee Pain
Clinical trial findings reveal significant pain reduction and strong safety profile for investigational topical gel VAS-101 in adults with knee osteoarthritis.
European Commission Approves Needle-Free Adrenaline Nasal Spray for Children with Severe Allergies
ALK’s EURneffy 1 mg expands access to needle-free emergency treatment for anaphylaxis in children aged 4 and above across the EU.
Symeres Partners Ambagon Therapeutics to Advance Molecular Glue Research for Cancer Treatment
The collaboration will evaluate novel small-molecule “molecular glues” to target colorectal cancer and other hard-to-treat diseases, aiming to expand next-generation drug discovery approaches.
Rusan Healthcare Launches APOSAN 3ml Pen for Advanced Parkinson's Treatment in India
The new multi-dose apomorphine delivery device aims to simplify self-administration and improve management of ‘ON-OFF’ episodes in Parkinson’s patients.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy